Commentary on 'How the debate about comparative effectiveness research (CER) should impact the future of clinical trials' by Michael S. Lauer.
Center for Clinical Epidemiology and Biostatistics, Division of Biostatistics Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, U.S.A. jellenbe@mail.med.upenn.edu
Jonas H
JH
Ellenberg
D057186:Comparative Effectiveness Research / Q000458:organization & administration*; D016032:Randomized Controlled Trials as Topic / Q000592:standards*